These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25010421)

  • 1. Experimental infection of the pig with Mycobacterium ulcerans: a novel model for studying the pathogenesis of Buruli ulcer disease.
    Bolz M; Ruggli N; Ruf MT; Ricklin ME; Zimmer G; Pluschke G
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2968. PubMed ID: 25010421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.
    Bolz M; Ruggli N; Borel N; Pluschke G; Ruf MT
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004678. PubMed ID: 27128097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig Model.
    Silva-Gomes R; Marcq E; Trigo G; Gonçalves CM; Longatto-Filho A; Castro AG; Pedrosa J; Fraga AG
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004265. PubMed ID: 26625302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultraviolet radiation enhances both the nodular and ulcerative forms of Mycobacterium ulcerans infection in a Crl:IAF(HA)-hrBR hairless guinea pig model of Buruli ulcer disease.
    Cope RB; Hartman JA; Morrow CK; Haschek WM; Small PL
    Photodermatol Photoimmunol Photomed; 2002 Dec; 18(6):271-9. PubMed ID: 12535022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?
    Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection.
    Martins TG; Gama JB; Fraga AG; Saraiva M; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(2):e32740. PubMed ID: 22393444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.
    Bieri R; Bolz M; Ruf MT; Pluschke G
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004450. PubMed ID: 26863011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis.
    Ruf MT; Bolz M; Vogel M; Bayi PF; Bratschi MW; Sopho GE; Yeboah-Manu D; Um Boock A; Junghanss T; Pluschke G
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004767. PubMed ID: 27253422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.
    Ruf MT; Schütte D; Chauffour A; Jarlier V; Ji B; Pluschke G
    Antimicrob Agents Chemother; 2012 Feb; 56(2):687-96. PubMed ID: 22143518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Imaging of Bioluminescent
    Omansen TF; Marcsisin RA; Chua BY; Zeng W; Jackson DC; Porter JL; Stienstra Y; van der Werf TS; Stinear TP
    Am J Trop Med Hyg; 2019 Dec; 101(6):1312-1321. PubMed ID: 31595865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buruli ulcer (Mycobacterium ulcerans infection).
    Walsh DS; Portaels F; Meyers WM
    Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental Survival of Mycobacterium ulcerans in Watery Soil, a Potential Source of Buruli Ulcer.
    Tian RD; Lepidi H; Nappez C; Drancourt M
    Am J Trop Med Hyg; 2016 Jan; 94(1):89-92. PubMed ID: 26526927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and histologic features of skin lesions in a cynomolgus monkey experimentally infected with mycobacterium ulcerans (Buruli ulcer) by intradermal inoculation.
    Walsh DS; Dela Cruz EC; Abalos RM; Tan EV; Walsh GP; Portaels F; Meyers WM
    Am J Trop Med Hyg; 2007 Jan; 76(1):132-4. PubMed ID: 17255241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Mycobacterium ulcerans in the environment predicts prevalence of Buruli ulcer in Benin.
    Williamson HR; Benbow ME; Campbell LP; Johnson CR; Sopoh G; Barogui Y; Merritt RW; Small PL
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1506. PubMed ID: 22303498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical exposure to exogenous ultraviolet-irradiated urocanic acid enhances Mycobacterium ulcerans infection in a Crl:IAF(HA)-hrBR hairless guinea-pig model of Buruli ulcer disease.
    Cope RB; Stang B; Valentine BA; Bermudez LE
    Photodermatol Photoimmunol Photomed; 2004 Feb; 20(1):14-20. PubMed ID: 14738528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe cases of Buruli ulcer (infection with Mycobacterium ulcerans) in common ringtail possums in Victoria adversely affect animal welfare.
    Hobbs EC; Loukopoulos P; Stinear TP; Porter JL; Lee J; Whiteley P; Skerratt LF; Gibney KB; Meredith A
    Aust Vet J; 2024 Oct; 102(10):517-523. PubMed ID: 39054806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model.
    Trigo G; Martins TG; Fraga AG; Longatto-Filho A; Castro AG; Azeredo J; Pedrosa J
    PLoS Negl Trop Dis; 2013; 7(4):e2183. PubMed ID: 23638204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infection.
    Zhang T; Li SY; Converse PJ; Grosset JH; Nuermberger EL
    PLoS Negl Trop Dis; 2013; 7(12):e2598. PubMed ID: 24367713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium ulcerans Population Genomics To Inform on the Spread of Buruli Ulcer across Central Africa.
    Vandelannoote K; Phanzu DM; Kibadi K; Eddyani M; Meehan CJ; Jordaens K; Leirs H; Portaels F; Stinear TP; Harris SR; de Jong BC
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30728280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of rifalazil (KRM-1648) in a M. ulcerans-induced Buruli ulcer mouse model.
    Fukano H; Nakanaga K; Goto M; Yoshida M; Ishii N; Hoshino Y
    PLoS One; 2022; 17(10):e0274742. PubMed ID: 36201529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.